RADI-19. The Incidence of New Brain Metastases in Patients with Non-Small Cell Lung Cancer Following Discontinuation of Systemic Therapy
Dennis London(NYU Langone Health), Douglas Kondziolka(Neurological Surgery), Joshua K. Sabari(NYU Langone Health), R. España Navarro(NYU Langone Health), Amy Palermo(NYU Langone Health), Erik P. Sulman(NYU Langone Health), Abraham Chachoua(New York University), Vamsidhar Velcheti(Cleveland Clinic), Kenneth Bernstein(NYU Langone Health), Elaine Shum(NYU Langone’s Laura and Isaac Perlmutter Cancer Center), Joshua S. Silverman(NYU Langone Health), Bernadine Donahue(Maimonides Medical Center), Jason Gurewitz(New York University), Dev Patel(NYU Langone Health), John G. Golfinos(NYU Langone Health)
Cited by 0
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation
|New England Journal of Medicine|2021|1.8k
Radiotherapy induces responses of lung cancer to CTLA-4 blockade
|Nature Medicine|2018|927
Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|835
Predicting cancer outcomes with radiomics and artificial intelligence in radiology
|Nature Reviews Clinical Oncology|2021|810